News

Newsletter

3 de February de 2017

Amendments to TRIPs in order to ease access to medicines are now in force

After the ratifications of 2/3 of WTO (World Trade Organization) members, article 31 bis was formally brought into the text of TRIPs Agreement. Such provision aims at allowing compulsory licenses for export in order to meet the needs of countries with insufficient or no capacity of manufacturing drugs. It is a direct result of Doha Declaration on TRIPs Agreement and Public Health of 2001, which aims at striking a balance between IP protection and access to health care.
 
In line with such amendment to TRIPs, a least developed country or a country that has notified the WTO (World Trade Organization) of its lack of capacity of manufacturing a specific drug in order to meet its own needs are eligible to obtain compulsory licenses to import such drug from a third country under special conditions. Such compulsory license shall be paid and limited to the purpose of meeting the needs of the importing country. Moreover, measures shall be taken to assure that the patentee rights shall not be hampered in the exporting country. In the past, there were negotiations concerning compulsory licenses for export during the Avian flu pandemic in 2005. Some Asian countries pressured WTO to allow compulsory licenses to import generic copies of Tamiflu®. Before any license was ever implemented, countries and the manufacturer struck a deal.
 
Article 31 bis formally entered into force on January 23.
 
We shall keep you informed about the next updates of this subject. In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com.
 
Back

Last related news

6 de May de 2025

Legal Protection for Developers: Compensation for Irregular Licenses

Our firm recently secured another important court victory on behalf of a software developer client in a lawsuit against a company that Legal Protection for Developers: Compensation for Irregular Licenses

  • Kasznar Leonardos
  • Ler notícia

    24 de April de 2025

    Third Parties and Software Piracy: Companies Remain Legally Responsible

    During software compliance audits, it is not uncommon for companies to claim that pirated programs were installed by external contractors or IT Third Parties and Software Piracy: Companies Remain Legally Responsible

  • Kasznar Leonardos
  • Ler notícia

    16 de April de 2025

    Medicinal Cannabis Review: Public Consultation 1.316/2025 open

    The Public Consultation (CP) No. 1.316/2025, which aims to initiate the review process of Collegiate Board Resolution (RDC) No. 327/2019 from the Medicinal Cannabis Review: Public Consultation 1.316/2025 open

    Ler notícia
    plugins premium WordPress